Andrew Dahlem

Andrew M.
Dahlem is the founder of Gate Neurosciences, Inc. Current jobs include Professor at The Ohio State University, Professor at Purdue University, Member of the American Association of Pharmaceutical Scientists, Executive Vice President-Operations at Lilly Research Laboratories since 2011, Member of the Society of Toxicology, and Member of the International Society for the Study of Xenobiotics.
Former jobs include Chairman at Syra Health Corp.
from 2023 to 2025, Director at Indigo BioAutomation, Inc., President at Hypnion, Inc., and Member of the American Association for the Advancement of Science.
Education includes an undergraduate degree from The Ohio State University conferred in 1982, a doctorate from the University of Illinois conferred in 1989, and a doctorate from the College of Veterinary Medicine.